Minoru Ueki

No ORCID on file · 15 papers in corpus · active 1980-2006

Study types

  • article 14
  • book-chapter 1

Condition tags

  • endometriosis 12
  • mesh:D004715 6
  • infertility 1
  • adenomyosis 1
article 2006
Molecular human reproduction ·doi:10.1093/molehr/gal042

Survivin is a novel inhibitor of apoptosis (IAP), and the two splice variants of survivin (survivin-2B and survivin-EX3) have been identified. Gene expression levels of survivin, survivin-2B and survivin-EX3 in 56 ectopic (16 peritoneal red…

article 2005
article 2004
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/01.pgp.0000130109.80359.57

The biologic properties of adenomyosis and the effects of therapeutic agents on adenomyosis were evaluated with immunohistochemistry, terminal deoxy-nucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) method, transmission…

article 2004
Human pathology ·doi:10.1016/j.humpath.2004.07.020
book-chapter 2003
·doi:10.1007/978-4-431-53981-0_18
article 2003
article 2002
Fertility and Sterility ·doi:10.1016/s0015-0282(02)03339-3
article 2002
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.87.7.8682

Survivin is a novel inhibitor of apoptosis and is expressed during fetal development and in cancer tissues, but its expression has not been reported in normal adult tissues or benign diseases. We investigated survivin gene and protein expre…

article 1997

The effects of two kinds of erythropoietin (EPO), and the effectiveness and safety of predeposit autologous blood transfusion (PAT) were examined in patients with uterine myoma or endometriosis who underwent simple total hysterectomy. EPO w…

article 1996

The safety and efficacy of intraoperative autologous blood transfusion in abdominal simple total hysterectomy for endometriosis were examined. Four patients were treated using intraoperative salvage apparatus, Cell Saver, Haemo Lite 2. Bloo…

article 1995
·doi:10.1111/j.1447-0756.1995.tb00889.x

The following results were obtained from our investigations performed to compare the effects of danazol (400 mg/day orally for 4 to 6 months, n = 164) with those of buserelin (900 micrograms/day intranasally for 4 to 6 months, n = 83) on pa…

article 1994
Asia-Oceania journal of obstetrics and gynaecology ·doi:10.1111/j.1447-0756.1994.tb00492.x

Endometriosis is often associated with infertility, which might be a consequence of intraperitoneal macrophage activation and various immunological events related to it. To determine what triggers macrophage activation and what immunologic …

article 1991
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(91)90252-m
article 1981
·doi:10.5795/jjscc.20.92

子宮頸部境界病変の診断は組織学的に行われているが, 形態学だけでこれらの病変のもつ良性, 悪性などの生物学的性質のすべてを知ることはできない. そこで子宮内膜症を合併する異形成や上皮内癌において, EP合剤による偽妊娠療法やdanazol療法で内膜症を治療するとともに, 頸部病変の変化を剥離細胞診によって観察し, 組織学的異形度と各病変の生物学的性質との関係をhormone反応性の面から検討した. さらに異常上皮における鑑別診断や治療法としての可能性について考察した.その結果…

article 1980